A recent study found that toxicity is routinely minimized in phase 3 oncology trials, especially those that are not industry ...

The first patient has been enrolled in the phase 3 PROSTATE-IQ trial being conducted in men with prostate cancer recurrence ...

Proportion increases when considering off-label use but drops when considering drugs with substantial clinical benefit.

The Society of Surgical Oncology ... offer PIPAC in a clinical trial, and has hosted the first and second U.S. PIPAC training workshops. The City of Hope-led multicenter phase 1 trial, in ...

Results from the NRG Oncology GOG-0263 Phase III clinical trial testing the addition of cisplatin-based chemotherapy to ...

Phase 2 trial design will seek to maximise radiation doses to tumor and extend the duration of therapy, with first metastatic ...

The combination of sintilimab and fruquintinib received conditional approval from China’s National Medical Products Administration (NMPA) for the treatment of patients with advanced endometrial cancer ...

Dr. Frankis Almaguel, Director of the Molecular Imaging and Therapeutics Nuclear Oncology Program at ... encouraging results in previous Phase 1 and 2 trials. There remains significant unmet ...

Targeted chemotherapy in the abdomen using a technique called PIPAC combined with systemic standard-of-care chemotherapy is shown to be safe, with promising activity for patients with colorectal and a ...

Men who experience acute adverse effects after radiation therapy for prostate cancer may be at higher risk for more serious ...

Researchers from the University of Chicago Medicine Comprehensive Cancer Center have demonstrated the potential of a novel ...